Compare ASYS & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASYS | EMBC |
|---|---|---|
| Founded | 1981 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.3M | 279.9M |
| IPO Year | 2006 | 2021 |
| Metric | ASYS | EMBC |
|---|---|---|
| Price | $14.98 | $5.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | 304.0K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | 0.19 | ★ 1.03 |
| Revenue | ★ $79,364,000.00 | N/A |
| Revenue This Year | $2.82 | $1.17 |
| Revenue Next Year | $18.75 | N/A |
| P/E Ratio | $74.89 | ★ $5.12 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.75 | $2.77 |
| 52 Week High | $25.71 | $14.91 |
| Indicator | ASYS | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 51.10 | 55.61 |
| Support Level | $13.69 | $4.84 |
| Resistance Level | $15.87 | $5.77 |
| Average True Range (ATR) | 0.63 | 0.27 |
| MACD | 0.05 | -0.06 |
| Stochastic Oscillator | 74.41 | 35.58 |
Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.